In β-cells, the absence of XBP1s results in defects in proinsulin processing, impaired insulin secretion, and a loss of β-cell adaptive proliferation, leading to reduced glucose tolerance and hyperglycemia (Lee et al., 2011; Lee et al., 2022). The gene discussed is INS; the disease is Hyperglycemia.